Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Asia-Pacific and Middle East Medical Implants Market by PRODUCT (ORTHOPEDIC IMPLANTS, CARDIOVASCULAR IMPLANTS, SPINAL IMPLANTS, NEUROSTIMULATORS, OPHTHALMIC IMPLANTS, DENTAL IMPLANTS, BREAST IMPLANTS, FACIAL IMPLANTS) and by BIOMATERIAL (METALLIC BIOMATERIAL, CERAMIC BIOMATERIAL, POLYMERS BIOMATERIAL, NATURAL BIOMATERIAL): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04472

Pages: NA

Charts: NA

Tables: NA

 Key Market Segments

  • By PRODUCT
    • ORTHOPEDIC IMPLANTS
    • CARDIOVASCULAR IMPLANTS
    • SPINAL IMPLANTS
    • NEUROSTIMULATORS
    • OPHTHALMIC IMPLANTS
    • DENTAL IMPLANTS
    • BREAST IMPLANTS
    • FACIAL IMPLANTS
  • By BIOMATERIAL
    • METALLIC BIOMATERIAL
    • CERAMIC BIOMATERIAL
    • POLYMERS BIOMATERIAL
    • NATURAL BIOMATERIAL
  • By Region
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • GE Healthcare
  • Philips
  • Zimmer Biomet
  • Johnson & Johnson
  • Smith & Nephew
  • Stryker Corporation
  • B.Braun Melsungen AG
  • Intuitive Surgical
  • Baxter International Inc.
  • Medtronic

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. ORTHOPEDIC IMPLANTS

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. CARDIOVASCULAR IMPLANTS

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. SPINAL IMPLANTS

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. NEUROSTIMULATORS

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. OPHTHALMIC IMPLANTS

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. DENTAL IMPLANTS

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. BREAST IMPLANTS

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

    • 4.9. FACIAL IMPLANTS

      • 4.9.1. Key Market Trends, Growth Factors and Opportunities

      • 4.9.2. Market Size and Forecast, By Region

      • 4.9.3. Market Share Analysis, By Country

  • CHAPTER 5: ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET, BY BIOMATERIAL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Biomaterial

    • 5.2. METALLIC BIOMATERIAL

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. CERAMIC BIOMATERIAL

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. POLYMERS BIOMATERIAL

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. NATURAL BIOMATERIAL

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Biomaterial

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S.

        • 6.2.5.1 Market size and forecast, product

        • 6.2.5.2 Market size and forecast, biomaterial

      • 6.2.6. Canada

        • 6.2.6.1 Market size and forecast, product

        • 6.2.6.2 Market size and forecast, biomaterial

      • 6.2.7. Mexico

        • 6.2.7.1 Market size and forecast, product

        • 6.2.7.2 Market size and forecast, biomaterial

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Biomaterial

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France

        • 6.3.5.1 Market size and forecast, product

        • 6.3.5.2 Market size and forecast, biomaterial

      • 6.3.6. Germany

        • 6.3.6.1 Market size and forecast, product

        • 6.3.6.2 Market size and forecast, biomaterial

      • 6.3.7. Italy

        • 6.3.7.1 Market size and forecast, product

        • 6.3.7.2 Market size and forecast, biomaterial

      • 6.3.8. Spain

        • 6.3.8.1 Market size and forecast, product

        • 6.3.8.2 Market size and forecast, biomaterial

      • 6.3.9. UK

        • 6.3.9.1 Market size and forecast, product

        • 6.3.9.2 Market size and forecast, biomaterial

      • 6.3.10. Russia

        • 6.3.10.1 Market size and forecast, product

        • 6.3.10.2 Market size and forecast, biomaterial

      • 6.3.11. Rest Of Europe

        • 6.3.11.1 Market size and forecast, product

        • 6.3.11.2 Market size and forecast, biomaterial

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Biomaterial

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China

        • 6.4.5.1 Market size and forecast, product

        • 6.4.5.2 Market size and forecast, biomaterial

      • 6.4.6. Japan

        • 6.4.6.1 Market size and forecast, product

        • 6.4.6.2 Market size and forecast, biomaterial

      • 6.4.7. India

        • 6.4.7.1 Market size and forecast, product

        • 6.4.7.2 Market size and forecast, biomaterial

      • 6.4.8. South Korea

        • 6.4.8.1 Market size and forecast, product

        • 6.4.8.2 Market size and forecast, biomaterial

      • 6.4.9. Australia

        • 6.4.9.1 Market size and forecast, product

        • 6.4.9.2 Market size and forecast, biomaterial

      • 6.4.10. Thailand

        • 6.4.10.1 Market size and forecast, product

        • 6.4.10.2 Market size and forecast, biomaterial

      • 6.4.11. Malaysia

        • 6.4.11.1 Market size and forecast, product

        • 6.4.11.2 Market size and forecast, biomaterial

      • 6.4.12. Indonesia

        • 6.4.12.1 Market size and forecast, product

        • 6.4.12.2 Market size and forecast, biomaterial

      • 6.4.13. Rest of Asia Pacific

        • 6.4.13.1 Market size and forecast, product

        • 6.4.13.2 Market size and forecast, biomaterial

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Biomaterial

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil

        • 6.5.5.1 Market size and forecast, product

        • 6.5.5.2 Market size and forecast, biomaterial

      • 6.5.6. South Africa

        • 6.5.6.1 Market size and forecast, product

        • 6.5.6.2 Market size and forecast, biomaterial

      • 6.5.7. Saudi Arabia

        • 6.5.7.1 Market size and forecast, product

        • 6.5.7.2 Market size and forecast, biomaterial

      • 6.5.8. UAE

        • 6.5.8.1 Market size and forecast, product

        • 6.5.8.2 Market size and forecast, biomaterial

      • 6.5.9. Argentina

        • 6.5.9.1 Market size and forecast, product

        • 6.5.9.2 Market size and forecast, biomaterial

      • 6.5.10. Rest of LAMEA

        • 6.5.10.1 Market size and forecast, product

        • 6.5.10.2 Market size and forecast, biomaterial

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Stryker Corporation

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Johnson And Johnson

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Zimmer Biomet

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Smith And Nephew

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Medtronic

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. B.Braun Melsungen AG

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. GE Healthcare

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Intuitive Surgical

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Philips

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Baxter International Inc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR ORTHOPEDIC IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR CARDIOVASCULAR IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR SPINAL IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR NEUROSTIMULATORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR OPHTHALMIC IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR DENTAL IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR BREAST IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR FACIAL IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 11. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR METALLIC BIOMATERIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR CERAMIC BIOMATERIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR POLYMERS BIOMATERIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR NATURAL BIOMATERIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 19. U.S. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. U.S. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 21. CANADA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. CANADA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 28. FRANCE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. FRANCE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 30. GERMANY ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 32. ITALY ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. ITALY ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 34. SPAIN ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. SPAIN ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 36. UK ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. UK ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 38. RUSSIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. RUSSIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 40. REST OF EUROPE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. REST OF EUROPE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 42. ASIA-PACIFIC ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. ASIA-PACIFIC ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 44. ASIA-PACIFIC ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 45. CHINA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. CHINA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 47. JAPAN ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. JAPAN ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 49. INDIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. INDIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 51. SOUTH KOREA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. SOUTH KOREA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 53. AUSTRALIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. AUSTRALIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 55. THAILAND ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. THAILAND ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 57. MALAYSIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. MALAYSIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 59. INDONESIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. INDONESIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 61. REST OF ASIA PACIFIC ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. REST OF ASIA PACIFIC ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 63. LAMEA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. LAMEA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 65. LAMEA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 66. BRAZIL ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 67. BRAZIL ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH AFRICA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH AFRICA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 70. SAUDI ARABIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. SAUDI ARABIA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 72. UAE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. UAE ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 74. ARGENTINA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. ARGENTINA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 76. REST OF LAMEA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. REST OF LAMEA ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 78. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 79. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 80. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 81. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 82. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 84. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 85. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 86. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 87. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. ZIMMER BIOMET: KEY EXECUTIVES
  • TABLE 89. ZIMMER BIOMET: COMPANY SNAPSHOT
  • TABLE 90. ZIMMER BIOMET: OPERATING SEGMENTS
  • TABLE 91. ZIMMER BIOMET: PRODUCT PORTFOLIO
  • TABLE 92. ZIMMER BIOMET: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 94. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 95. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 96. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 97. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. MEDTRONIC: KEY EXECUTIVES
  • TABLE 99. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 100. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 101. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 102. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. B.BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 104. B.BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 105. B.BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 106. B.BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 107. B.BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 109. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 110. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 111. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 112. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. INTUITIVE SURGICAL: KEY EXECUTIVES
  • TABLE 114. INTUITIVE SURGICAL: COMPANY SNAPSHOT
  • TABLE 115. INTUITIVE SURGICAL: OPERATING SEGMENTS
  • TABLE 116. INTUITIVE SURGICAL: PRODUCT PORTFOLIO
  • TABLE 117. INTUITIVE SURGICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. PHILIPS: KEY EXECUTIVES
  • TABLE 119. PHILIPS: COMPANY SNAPSHOT
  • TABLE 120. PHILIPS: OPERATING SEGMENTS
  • TABLE 121. PHILIPS: PRODUCT PORTFOLIO
  • TABLE 122. PHILIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 124. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 125. BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
  • TABLE 126. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 127. BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET
  • FIGURE 3. SEGMENTATION ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET
  • FIGURE 11. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 12. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR ORTHOPEDIC IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR SPINAL IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR NEUROSTIMULATORS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR OPHTHALMIC IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR DENTAL IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR BREAST IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR FACIAL IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET SEGMENTATION, BY BIOMATERIAL
  • FIGURE 21. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR METALLIC BIOMATERIAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR CERAMIC BIOMATERIAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR POLYMERS BIOMATERIAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET FOR NATURAL BIOMATERIAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: ASIA-PACIFIC AND MIDDLE EAST MEDICAL IMPLANTS MARKET
  • FIGURE 31. TOP PLAYER POSITIONING,2022
  • FIGURE 32. STRYKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. JOHNSON AND JOHNSON: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. ZIMMER BIOMET: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. ZIMMER BIOMET: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. ZIMMER BIOMET: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. SMITH AND NEPHEW: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. B.BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. B.BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. B.BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. GE HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. INTUITIVE SURGICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. INTUITIVE SURGICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. INTUITIVE SURGICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. PHILIPS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. PHILIPS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. PHILIPS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
Asia-Pacific and Middle East Medical Implants Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved